全文获取类型
| 收费全文 | 5215篇 |
| 免费 | 479篇 |
| 国内免费 | 15篇 |
专业分类
| 耳鼻咽喉 | 64篇 |
| 儿科学 | 199篇 |
| 妇产科学 | 93篇 |
| 基础医学 | 590篇 |
| 口腔科学 | 76篇 |
| 临床医学 | 569篇 |
| 内科学 | 879篇 |
| 皮肤病学 | 48篇 |
| 神经病学 | 472篇 |
| 特种医学 | 241篇 |
| 外科学 | 817篇 |
| 综合类 | 108篇 |
| 一般理论 | 6篇 |
| 预防医学 | 767篇 |
| 眼科学 | 123篇 |
| 药学 | 323篇 |
| 中国医学 | 11篇 |
| 肿瘤学 | 323篇 |
出版年
| 2022年 | 41篇 |
| 2021年 | 84篇 |
| 2020年 | 52篇 |
| 2019年 | 76篇 |
| 2018年 | 90篇 |
| 2017年 | 82篇 |
| 2016年 | 83篇 |
| 2015年 | 84篇 |
| 2014年 | 144篇 |
| 2013年 | 179篇 |
| 2012年 | 290篇 |
| 2011年 | 289篇 |
| 2010年 | 189篇 |
| 2009年 | 151篇 |
| 2008年 | 215篇 |
| 2007年 | 268篇 |
| 2006年 | 290篇 |
| 2005年 | 245篇 |
| 2004年 | 219篇 |
| 2003年 | 188篇 |
| 2002年 | 181篇 |
| 2001年 | 127篇 |
| 2000年 | 136篇 |
| 1999年 | 90篇 |
| 1998年 | 77篇 |
| 1997年 | 60篇 |
| 1996年 | 50篇 |
| 1995年 | 48篇 |
| 1994年 | 50篇 |
| 1993年 | 46篇 |
| 1992年 | 120篇 |
| 1991年 | 91篇 |
| 1990年 | 96篇 |
| 1989年 | 107篇 |
| 1988年 | 101篇 |
| 1987年 | 90篇 |
| 1986年 | 76篇 |
| 1985年 | 74篇 |
| 1984年 | 72篇 |
| 1983年 | 43篇 |
| 1982年 | 37篇 |
| 1981年 | 39篇 |
| 1980年 | 41篇 |
| 1979年 | 56篇 |
| 1977年 | 41篇 |
| 1976年 | 36篇 |
| 1974年 | 33篇 |
| 1972年 | 37篇 |
| 1969年 | 32篇 |
| 1966年 | 34篇 |
排序方式： 共有5709条查询结果，搜索用时 0 毫秒
101.
102.
Robert E Blair Laxmikant S Deshpande Robert J DeLorenzo 《Expert opinion on pharmacotherapy》2015,16(13):1911-1914
Cannabinoids have been used medicinally for centuries, and in the last decade, attention has focused on their broad therapeutic potential particularly in seizure management. While some cannabinoids have demonstrated anticonvulsant activity in experimental studies, their efficacy for managing clinical seizures has not been fully established. This commentary will touch on our understanding of the brain endocannabinoid system’s regulation of synaptic transmission in both physiological and pathophysiological conditions, and review the findings from both experimental and clinical studies on the effectiveness of cannabinoids to suppress epileptic seizures. At present, there is preliminary evidence that non-psychoactive cannabinoids may be useful as anticonvulsants, but additional clinical trials are needed to fully evaluate the efficacy and safety of these compounds for the treatment of epilepsy. 相似文献
103.
104.
Insulin receptors on leukemia and lymphoma cells 总被引：1，自引：0，他引：1
Tumor cells obtained from leukemia and lymphoma patients were investigated for specific insulin receptors. Using radioactive 125I- labeled insulin, specific insulin binding sites were demonstrated on most acute lymphocytic leukemia (ALL) and acute myelocytic leukemia (AML) cells, including acute promyelocytic leukemia (APL), chronic myelocytic leukemia (CML), and acute monocytic leukemia (AMoL) cells. Insulin receptors were not found on chronic lymphocytic leukemia (CLL) and malignant lymphoma (ML) cells. Specific insulin binding sites were also found on monocytes and thymocytes after treatment with phytohemagglutinin (PHA-P), but not on inactivated tonsil cells, peripheral blood lymphocytes, or thymocytes. There was no inverse correlation between the content of insulin receptors and the basal level of circulating insulin. These data suggest that the insulin receptor may be a new marker of acute leukemia and chronic myelocytic leukemia. 相似文献
105.
106.
107.
108.
Esmée A. Bakker Duck-chul Lee Xuemei Sui Thijs M.H. Eijsvogels Francisco B. Ortega I-Min Lee Carl J. Lavie Steven N. Blair 《Mayo Clinic proceedings. Mayo Clinic》2018,93(4):419-428
Objective
To examine the associations of resistance exercise, independent of and combined with aerobic exercise, with the risk of development of hypercholesterolemia in men.Patients and Methods
This study used data from the Aerobics Center Longitudinal Study, which is a cohort examining the associations of clinical and lifestyle factors with the development of chronic diseases and mortality. Participants received extensive preventive medical examinations at the Cooper Clinic in Dallas, Texas, between January 1, 1987, and December 31, 2006. A total of 7317 men aged 18 to 83 years (mean age, 46 years) without hypercholesterolemia at baseline were included. Frequency (times per week) and total amount (min/wk) of resistance and aerobic exercise were determined by self-report. Hypercholesterolemia was defined as a total cholesterol level of 240 mg/dL or higher or physician diagnosis.Results
During a median (interquartile range) follow-up of 4 (2 to 7) years, hypercholesterolemia developed in 1430 of the 7317 men (20%). Individuals meeting the resistance exercise guidelines (≥2 d/wk) had a 13% lower risk of development of hypercholesterolemia (hazard ratio [HR], 0.87; 95% CI, 0.76-0.99; P=.04) after adjustment for general characteristics, lifestyle factors, and aerobic exercise. In addition, less than 1 h/wk and 2 sessions per week of resistance exercise were associated with 32% and 31% lower risks of hypercholesterolemia (HR, 0.68; 95% CI, 0.54-0.86; P=.001; and HR, 0.69; 95% CI, 0.54-0.88; P=.003), respectively, compared with no resistance exercise. Higher levels of resistance exercise did not provide benefits. Meeting both resistance and aerobic exercise guidelines (≥500 metabolic equivalent task min/wk) lowered the risk of development of hypercholesterolemia by 21% (HR, 0.79; 95% CI, 0.68-0.91; P=.002). compared with meeting none of the guidelines.Conclusion
Compared with no resistance exercise, less than 1 h/wk of resistance exercise, independent of aerobic exercise, is associated with a significantly lower risk of development of hypercholesterolemia in men (P=.001). However, the lowest risk of hypercholesterolemia was found at 58 min/wk of resistance exercise. This finding suggests that resistance exercise should be encouraged to prevent hypercholesterolemia in men. However, future studies with a more rigorous analysis including major potential confounders (eg, diet, medications) are warranted. 相似文献109.
110.